• SHAREHOLDER ALERT: WeissLaw LLP Reminds PTI, BMCH, and MOBL Shareholders About Its Ongoing Investigations marketscreener.com Thu, 20 Mar 2025 04:50:41 GMT
• Kineta sells Genentech and Merck deals to investor ahead of TuHURA merger Fierce Biotech Mon, 10 Feb 2025 08:00:00 GMT
• yumanity therapeutics announces filing of registration statement on form s-4 in connection with proposed asset sale to janssen and... AsiaOne Sat, 05 Oct 2024 14:15:00 GMT
• yumanity therapeutics (nasdaq:ymtx) stock price up 2.4% Defense World Wed, 24 Jul 2024 07:00:00 GMT
• proteostatis therapeutics | biotechnology | the pharmaletter The Pharma Letter Sun, 30 Jun 2024 07:00:00 GMT
• 2024 Transformational Leadership Award N. Anthony Coles, MD'86, MPH Duke University School of Medicine Wed, 26 Jun 2024 07:00:00 GMT
• yumanity to reverse merge with kineta two years after its own public debut Scrip Sun, 07 Apr 2024 03:47:51 GMT
• yumanity therapeutics (nasdaq:ymtx) shares down 1.6% American Banking News Fri, 08 Mar 2024 08:00:00 GMT
• yumanity therapeutics (nasdaq:ymtx) stock price down 1.6% Defense World Fri, 08 Mar 2024 07:43:41 GMT
• kineta ceo laid off as cutbacks leave biotech with 4 employees The Business Journals Thu, 29 Feb 2024 08:00:00 GMT
• seattle biotech company kineta lays off majority of staff, including its ceo GeekWire Thu, 29 Feb 2024 08:00:00 GMT
• after saving yumanity's assets, kineta faces shutdown as private placement fails to show up Fierce Biotech Thu, 29 Feb 2024 08:00:00 GMT
• financial analysis: yumanity therapeutics (nasdaq:ymtx) & hepion pharmaceuticals (nasdaq:hepa) Defense World Tue, 12 Dec 2023 08:00:00 GMT
• kva-12123 by kineta for bladder cancer: likelihood of approval Pharmaceutical Technology Tue, 05 Dec 2023 04:36:45 GMT
• bristol myers' neuroscience research head explains the big ... BioPharma Dive Fri, 27 Oct 2023 07:00:00 GMT
• president joe biden commits to closing racial wealth gap during ... Black Enterprise Wed, 20 Sep 2023 07:00:00 GMT
• biden seeks cash in new york city from black donors for 2024 ... Bloomberg Mon, 18 Sep 2023 07:00:00 GMT
• neurofilament light chain as a mediator between lrrk2 mutation ... Nature.com Tue, 12 Sep 2023 07:00:00 GMT
• seattle biotech firm kineta averts nasdaq stock delisting - puget ... The Business Journals Thu, 17 Aug 2023 07:00:00 GMT
• new chain biotech funding to aid cadd therapeutic platform Labiotech.eu Fri, 28 Jul 2023 07:00:00 GMT
• pharming to nominate industry leader dr. richard peters as new ... PR Newswire Tue, 18 Jul 2023 07:00:00 GMT
• kineta to receive $5 million milestone payment from merck Yahoo Finance Thu, 29 Jun 2023 07:00:00 GMT
• alexandria sells 5 boston-area lab buildings to tpg joint venture Bisnow Wed, 14 Jun 2023 07:00:00 GMT
• Identifying 'gems' before others do: J&J exec gives insider's look at dealmaking spree Fierce Biotech Mon, 15 May 2023 07:00:00 GMT
• kineta raises $6m through registered direct offering - puget sound business journal The Business Journals Mon, 01 May 2023 07:00:00 GMT
• kineta raises $6m through registered direct offering The Business Journals Sun, 30 Apr 2023 07:00:00 GMT
• startups opt for microcap mergers to tap public markets Crunchbase News Thu, 02 Mar 2023 08:00:00 GMT
• magenta therapeutics to shut down after patient death - boston ... The Business Journals Fri, 03 Feb 2023 08:00:00 GMT
• boston-area biotechs goldfinch bio, theonys shut down - boston business journal Boston Business Journal Mon, 30 Jan 2023 08:00:00 GMT
• ytx-7739 exerts antitumor efficacy in models of glioblastoma through dnls targeting BioWorld Online Wed, 25 Jan 2023 08:00:00 GMT
• fierce biotech layoff tracker: layoffs strike 119 companies in 2022 FierceBiotech Tue, 03 Jan 2023 08:00:00 GMT
• 2022 turns out to be another unspectacular year for pharma and ... The Pharma Letter Mon, 02 Jan 2023 08:00:00 GMT
• kineta completes reverse merger with yumanity therapeutics StockTitan Mon, 19 Dec 2022 08:00:00 GMT
• kineta finalizes reverse merger with yumanity - puget sound business journal The Business Journals Mon, 19 Dec 2022 08:00:00 GMT
• kineta finalizes reverse merger with yumanity, secures additional funding The Business Journals Mon, 19 Dec 2022 08:00:00 GMT
• seattle biotech company kineta completes merger, begins trading on nasdaq GeekWire Mon, 19 Dec 2022 08:00:00 GMT
• washington: hub and spokane: life sciences and the science of ... Site Selection Magazine Mon, 12 Dec 2022 13:07:35 GMT
• yumanity declares special dividend related to asset sale, merger with kineta TipRanks Mon, 05 Dec 2022 08:00:00 GMT
• vod stock alert: what to know as vodafone says goodbye to ceo InvestorPlace Mon, 05 Dec 2022 08:00:00 GMT
• yumanity therapeutics reports third quarter 2022 financial results and recent corporate developments citybiz Mon, 14 Nov 2022 08:00:00 GMT
• yumanity therapeutics announces effectiveness of registration statement on form s-4 in connection with proposed ... GlobeNewswire Thu, 10 Nov 2022 08:00:00 GMT
• pic closes $35m series a to advance novel breast cancer therapeutic (updated) BioSpace Wed, 19 Oct 2022 07:00:00 GMT
• the 1001 imploded stocks of 2022 (down 80% or more)… so far WOLF STREET Mon, 17 Oct 2022 07:00:00 GMT
• sanofi-backed biotech hauls in $70m series a for covalent bonds FierceBiotech Fri, 14 Oct 2022 07:00:00 GMT
• gandeeva therapeutics appoints matthew lucas ph.d. as chief ... Business Wire Wed, 28 Sep 2022 07:00:00 GMT
• pretzel therapeutics launches with $72.5 million series a ... Business Wire Mon, 12 Sep 2022 07:00:00 GMT
• yumanity therapeutics announces filing of registration statement on form s-4 in connection with proposed asset sale to janssen and... citybiz Mon, 29 Aug 2022 07:00:00 GMT
• 10 health companies that have announced layoffs, hiring freezes ... Becker's ASC Review Mon, 15 Aug 2022 07:00:00 GMT
• the fall and rise of m&a investment in neuroscience The Pharma Letter Wed, 03 Aug 2022 07:00:00 GMT
• bose plans to close boston office, citing rise of remote work - boston ... Boston Business Journal Fri, 15 Jul 2022 07:00:00 GMT
• glioblastoma pipeline analysis: key pharma players set to develop ... Medgadget Thu, 14 Jul 2022 07:00:00 GMT
• yumanity selling neurology assets and merging with kineta Labiotech.eu Tue, 21 Jun 2022 07:00:00 GMT
• is yumanity therapeutics inc (ymtx) stock worth a buy tuesday? InvestorsObserver Tue, 14 Jun 2022 07:00:00 GMT
• Life sciences news: New startups, fundings, mergers, clinical trials, partnerships GeekWire Sat, 11 Jun 2022 07:00:00 GMT
• will yumanity therapeutics inc (ymtx) stay at the top of the healthcare sector? InvestorsObserver Thu, 09 Jun 2022 07:00:00 GMT
• inside kineta's plans after unveiling reverse merger deal The Business Journals Wed, 08 Jun 2022 07:00:00 GMT
• yumanity selling neurology assets and merging with kineta Labiotech.eu Tue, 07 Jun 2022 07:00:00 GMT
• aslan, yumanity, editas, janssen and more team up to fight disease BioSpace Tue, 07 Jun 2022 07:00:00 GMT
• yumanity therapeutics to sell its pipeline, merge with seattle biotech The Business Journals Tue, 07 Jun 2022 07:00:00 GMT
• Yumanity’s days as an independent biotech come to a close BioPharma Dive Mon, 06 Jun 2022 07:00:00 GMT
• Yumanity's end: J&J pays $26M for neuroscience assets as reverse merger erases biotech Fierce Biotech Mon, 06 Jun 2022 07:00:00 GMT
• Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions GlobeNewswire Mon, 06 Jun 2022 07:00:00 GMT
• Seattle biotech Kineta will go public in deal with neurosciences company Yumanity Therapeutics GeekWire Mon, 06 Jun 2022 07:00:00 GMT
• why is yumanity therapeutics (ymtx) stock up 50% today? InvestorPlace Mon, 06 Jun 2022 07:00:00 GMT
• yumanity stock soars 46% on all-stock merger with kineta; lead product sale to j&j for $26m Seeking Alpha Mon, 06 Jun 2022 07:00:00 GMT
• yumanity's days as an independent biotech come to a close BioPharma Dive Mon, 06 Jun 2022 07:00:00 GMT
• following deep cuts, yumanity strikes a deal to sell drugs to j&j, hands the keys to genentech-partnered kineta Endpoints News Mon, 06 Jun 2022 07:00:00 GMT
• yumanity to reverse merge with kineta two years after its own public debut Citeline News & Insights Mon, 06 Jun 2022 07:00:00 GMT
• yumanity stock up 46% on all-stock merger with kineta; lead product sale to j&j for $26m Seeking Alpha Mon, 06 Jun 2022 07:00:00 GMT
• yumanity therapeutics inc (ymtx) is up 21.83% monday in premarket trading InvestorsObserver Mon, 06 Jun 2022 07:00:00 GMT
• boston has the largest potential pipeline of life science space in ... Boston Real Estate Times Fri, 20 May 2022 07:00:00 GMT
• ‘some biotech firms will not survive’: layoffs, closures, and mergers ... The Boston Globe Tue, 19 Apr 2022 07:00:00 GMT
• vesigen therapeutics appoints paulash mohsen as chief executive officer Business Wire Mon, 11 Apr 2022 07:00:00 GMT
• flagship’s kaleido biosciences shuts down, as more biotechs lay off ... The Boston Globe Fri, 08 Apr 2022 07:00:00 GMT
• 'stay alive': wave of layoffs crashes into biotech startup inferno FierceBiotech Mon, 28 Mar 2022 07:00:00 GMT
• what is the market's view on yumanity therapeutics inc (ymtx) stock's price and volume trends friday? InvestorsObserver Fri, 25 Mar 2022 07:00:00 GMT
• yumanity therapeutics reports full-year 2021 financial results and recent corporate developments Yahoo Finance Thu, 24 Mar 2022 07:00:00 GMT
• yumanity therapeutics inc (ymtx) has fallen 5.56% wednesday in premarket trading InvestorsObserver Wed, 23 Mar 2022 07:00:00 GMT
• healthcare stocks making moves monday: nrsn, ymtx, crxt, nxgl, vlon, vigl, cntb, cinc InvestorsObserver Mon, 21 Mar 2022 07:00:00 GMT
• premarket mover: yumanity therapeutics inc (ymtx) up 20.00% InvestorsObserver Fri, 18 Mar 2022 07:00:00 GMT
• frontotemporal dementia pipeline landscape analysis of 20+ ... GlobeNewswire Mon, 07 Mar 2022 08:00:00 GMT
• amicus spac spin-off unravels, spooling layoffs and restructuring BioSpace Fri, 25 Feb 2022 08:00:00 GMT
• yumanity therapeutics exploring strategic alternatives to enhance shareholder value and announces restructuring GlobeNewswire Thu, 17 Feb 2022 08:00:00 GMT
• after clinical hold, yumanity to cut 60% of workforce by april and hunt for a buyer Fierce Biotech Thu, 17 Feb 2022 08:00:00 GMT
• yumanity cutting 60% of employees as it mulls possible sale BioPharma Dive Thu, 17 Feb 2022 08:00:00 GMT
• yumanity cuts 60% of its workforce, explores strategic alternatives Yahoo Finance Thu, 17 Feb 2022 08:00:00 GMT
• yumanity therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4) Yahoo Finance Fri, 04 Feb 2022 08:00:00 GMT
• fda allows testing of parkinson's therapy ytx-7739 in single doses Parkinson's News Today Thu, 20 Jan 2022 08:00:00 GMT
• partial clinical hold placed on multidose clinical trials of ytx-7739 in parkinson disease Neurology Live Thu, 20 Jan 2022 08:00:00 GMT
• yumanity expresses confidence as parkinson’s therapy placed on partial hold BioSpace Wed, 19 Jan 2022 08:00:00 GMT
• yumanity reports partial clinical hold by u.s. fda on multidose clinical trials for ytx-7739 GlobeNewswire Wed, 19 Jan 2022 08:00:00 GMT
• yumanity expresses confidence as parkinson's therapy placed on partial hold BioSpace Wed, 19 Jan 2022 08:00:00 GMT
• starting a company … in another country Life Science Leader Magazine Mon, 17 Jan 2022 08:00:00 GMT
• Yumanity’s Approach to Neurodegenerative Diseases Validated by Two External Collaborations GlobeNewswire Tue, 11 Jan 2022 08:00:00 GMT
• yumanity's approach to neurodegenerative diseases validated GlobeNewswire Tue, 11 Jan 2022 08:00:00 GMT
• yumanity therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4) GlobeNewswire Wed, 05 Jan 2022 08:00:00 GMT
• yumanity therapeutics to present at the h.c. wainwright bioconnect conference GlobeNewswire Tue, 04 Jan 2022 08:00:00 GMT
• notable gsas alumni | gsas alumni | about us | graduate school ... Brandeis University Thu, 16 Dec 2021 19:22:37 GMT
• phase 1b trial of ytx-7739 shows safety, early potential in patients Parkinson's News Today Mon, 15 Nov 2021 08:00:00 GMT
• phase 1b parkinson's trial of ytx-7739 shows safety, early potential Parkinson's News Today Mon, 15 Nov 2021 08:00:00 GMT
• yumanity therapeutics announces positive top-line results of phase 1b clinical trial for ytx-7739 in patients with parkinson’s dis... GlobeNewswire Wed, 10 Nov 2021 08:00:00 GMT
• yumanity therapeutics stock plunges after parkinson's trial data Yahoo Finance Wed, 10 Nov 2021 08:00:00 GMT
• james barrett not to stand for re-election on the board of directors of proteostasis therapeutics, inc at its agm to be held on ju... Marketscreener.com Sat, 16 Oct 2021 18:21:45 GMT
• yumanity therapeutics provides update on its lead parkinson’s disease clinical program, ytx-7739 GlobeNewswire Sat, 02 Oct 2021 07:00:00 GMT
• delix raises $70m to test psychedelic analogs for treating brain ... FierceBiotech Mon, 27 Sep 2021 07:00:00 GMT
• targeting usp14, a protein that suppresses proteostasis Lifespan.io News Tue, 21 Sep 2021 17:29:02 GMT
• chutes & ladders—j&j ceo gorsky to step aside, handing world's ... FierceBiotech Fri, 20 Aug 2021 07:00:00 GMT
• yumanity therapeutics appoints michael d. wyzga as chief financial officer citybiz Mon, 16 Aug 2021 07:00:00 GMT
• yumanity therapeutics reports second quarter 2021 financial results and recent corporate developments GlobeNewswire Thu, 12 Aug 2021 07:00:00 GMT
• delix therapeutics continues rapid growth with appointment of chief medical officer PR Newswire Mon, 02 Aug 2021 07:00:00 GMT
• delix therapeutics appoints dr. brigitte robertson as chief medical officer citybiz Mon, 02 Aug 2021 07:00:00 GMT
• is parkinson's disease caused by dysfunctional lipids? Chemical & Engineering News Sun, 18 Jul 2021 07:00:00 GMT
• is yumanity therapeutics, inc. (ymtx) a good stock to buy? Yahoo Finance Mon, 28 Jun 2021 07:00:00 GMT
• chutes & ladders—trexbio snags new ceo from lilly as it prowls ... FierceBiotech Fri, 25 Jun 2021 07:00:00 GMT
• around the house: new gcs for abc and adtalem global education The Global Legal Post Fri, 18 Jun 2021 07:00:00 GMT
• yumanity therapeutics appoints devin w. smith as general counsel GlobeNewswire Mon, 14 Jun 2021 07:00:00 GMT
• yumanity therapeutics to present at upcoming virtual investor conferences GlobeNewswire Thu, 27 May 2021 07:00:00 GMT
• yumanity therapeutics’ r&d day reviews near-term value drivers and pipeline-generating discovery engine GlobeNewswire Mon, 17 May 2021 07:00:00 GMT
• chutes & ladders—former merck r&d chief perlmutter takes reins ... FierceBiotech Thu, 06 May 2021 07:00:00 GMT
Yumanity Therapeutics Inc(NASDAQ:YMTX) 
Yumanity Therapeutics Inc., a clinical-stage biopharmaceutical company, is dedicated to the research and development of treatments for neurodegenerative diseases caused by protein misfolding. The company is headquartered in Boston, Massachusetts.
Founded: 2014
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
Share this website to your friends